The older hypertensive

Blood Pressure

Volumn 10, Issue 5-6, 2001, Pages 299-310

  Birkenhäger, Willem H ^a   De Leeuw, Peter W ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Haemodynamics; Isolated systolic hypertension; Pulse pressure; Quality of life; Therapeutic issues

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; NEUROHORMONE; NITRENDIPINE; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; AGING; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIET; DRUG EFFICACY; EXERCISE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; AGE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; MIDDLE AGED; PHYSIOLOGY;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MIDDLE AGED;

EID: 0035527577     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370501753400601     Document Type: Review

References (77)

1. Inappropriate antihypertensive therapy in the elderly
2. Perspectives on systolic hypertension. The Framingham Study
3. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60
4. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
5. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension
6. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension
7. The prognosis of essential hypertension
8. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program
9. Randomised double-blind comparison of placebo and active treatment for older persons with isolated systolic hypertension
10. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives
11. Isolated systolic hypertension in the elderly
12. Pulse pressure:a predictor of long-term cardiovascular mortality in a French male population
13. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients
14. Pulsatile versus steady component of blood pressure: A cross-sectional and a prospective analysis on cardiovascular mortality
15. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study
16. Pulse pressure - A review of mechanisms and clinical relevance
17. Pulse pressure and resistance artery structure in the elderly
18. Stiffness of the common carotid artery in treated hypertensive patients
19. Age-related differences in blood pressure and heart rate responses to changes in body position: Results from a study with serial measurements in the supine and standing positions in 30-, 50- and 60-year-old men
20. Effects of age and isolated systolic hypertension on cardiovascular reflexes
21. Haemodynamic and endocrinological profile of essential hypertension
22. Effect of age on the hemodynamic response to posture in nonelderly hypertensive patients
23. Renal hemodynamics and glomerular filtration in essential hypertension; effects of treatment
24. Renal function and hemodynamic studies in low- and normal-renin essential hypertension
25. Renal and systemic hemodynamics in sustained essential hypertension
26. Accelerated decline in renal perfusion with aging in essential hypertension
27. Senescence and the renal vasculature in normal man
28. Renal response to propranolol treatment in hypertensive humans
29. Longitudinal studies on the rate of decline in renal function with age
30. Abnormal renal function sodium-volume homeostasis and renin system behavior in normal-renin essential hypertension: The evolution of the nonmodulator concept
31. Age as a determinant of renal sodium conservation in normal man
32. Sensitivity of blood pressure and renin activation during sodium restriction
33. Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments and renal function
34. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension
35. Relationship between basal and sodium-stimulated plasma atrial natriuretic factor, age, sex and blood pressure in normal man
36. Reduced renal hemodynamic response to atrial natriuretic peptide in elderly volunteers
37. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: The impact of aging
38. Human ageing and the sympathoadrenal system
39. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure
40. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors
41. Noradrenaline release and the pathophysiology of primary human hypertension
42. Regional norepinephrine turnover in human hypertension
43. How to assess sympathetic activity in humans
44. Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials
45. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
46. Combined effects of heart rate and pulse pressure on cardiovascular mortality acoording to age
47. 15 Year longitudinal study of blood pressure and dementia
48. Atherosclerosis, apolipoptotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
49. Effects of hypertension and its treatment on mental function
50. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension
51. Effects of ACE inhibitors, calcium antagonists, and other blood pressure lowering drugs: Results of prospectively designed overviews of randomised trials
52. Hypertension in the elderly. Implications and generalizability of randomized trials
53. Treatment of hypertension in the elderly
54. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta - Analysis of outcome trials
55. Randomised trial of treatment of hypertension in primary care
56. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-hypertension)
57. MRC trial of treatment of mild hypertension: Principal results
58. Medical Research Council trial of treatment of hypertension in older adults
59. (Syst-China): Comparison of active treatment and placebo for older patients with isolated systolic hypertension
60. Subgroup and per protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly
61. Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials
62. The Hypertension in the very Elderly Trial (HYVET)
63. Nonpharmacological intervention to reduce blood pressure in older patients with mild hypertension
64. Does sodium restriction lower blood pressure?
65. Salt sensitivity in hypertension in the elderly
66. Physical activity and coronary heart disease risk in men. Does the duration of exercise episodes predict risk?
67. Cardiovascular protection and blood pressure reduction: A meta-analysis
68. Randomised trial of old antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trialin Old Patients with Hypertension - 2 study
69. Morbidity and mortality in patients randomised to double-blind treatment with long-acting calcium blocker or diuretic in the International Nifedipine GITS Study Intervention as a Goal in Hypertensive Treatment (INSIGHT)
70. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
71. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
72. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
73. Antihypertensive treatment prevents dementia: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study
74. Effects of calcium channel blockade in older patients
75. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension
76. Quality of life of elderly patients with isolated systolic hypertension: Baseline data from the Syst-Eur Trial
77. Impact of the treatment of isolated systolic hypertension on behavioral variables